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ARTICLE HIGHLIGHTS 15 
16 
Type of Research: SVS PSO survey of clinical practice 17 
effects due to coronavirus, Covid-19 pandemic. 18 
Retrospective review of VQI venous registry volume 19 
between 1st Quarter of 2019 and 2020. 20 
21 
Key Findings: Seventy four percent of respondents 22 
adopted a restrictive pandemic operating policy to urgent 23 
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and emergent procedures.  One half of surgeons 1 
continued in hospital ‘time sensitive’ elective procedures 2 
despite policy shift.  A five-fold reduction in VQI venous 3 
(VV + IVCF) procedural volume was noted in 1st Quarter 4 
of 2020 with Data Manager re-assignment/furlough and 5 
case volume decline contributing.  Survey questions 6 
omitted ambulatory practice change impact. 7 
 8 
Take home Message: VQI venous case volume activity 9 
and registry data entry was sharply reduced during the 10 
initial phase of the Covid-19 pandemic as many vascular 11 
surgeons adopted a restrictive policy on vascular 12 





Table of Contents Summary    18 
SVS PSO surveys of VQI Data Managers and Physicians 19 
assessed policy changes in response to the coronavirus 20 
pandemic.  Registry volume entry for 1st Quarter of 2020 21 





In response to the pandemic, an abrupt pivot of VQI physician members away from standard 2 
clinical practice to a restrictive phase of emergent and urgent vascular procedures occurred.  The 3 
Society for Vascular Surgery Patient Safety Organization queried both data managers and 4 
physicians in May 2020.  Approximately three fourths (74%) of physicians adopted restrictive 5 
operating policies for urgent and emergent cases only, while one half proceeded with ‘time 6 
sensitive’ elective cases as urgent.  Data manager case entry was negatively affected by both low 7 
case volumes and staffing due to re-assignment or furlough.  Venous registry volumes were 8 
reduced five-fold in 1st Quarter of 2020 compared to a similar period in 2019. 9 
The consequences of delaying vascular procedures for ambulatory venous practice remain 10 
unknown with increased morbidity likely.  Challenges to determine venous thromboembolism 11 
mortality impact exist given difficulty in verifying ‘in home and extended care facility’ deaths.  12 
Further ramifications of a pandemic shutdown will likely be amplified if postponement of 13 
elective vascular care extends beyond a short window of time.  It will be important to monitor 14 
disease progression and case severity as a result of policy shifts adopted locally in response to 15 
pandemic surges. 16 
 17 
Impact of COVID-19 on the Society for Vascular Surgery Vascular Quality Initiative 18 
Venous Procedure Registries (Varicose Vein and Inferior Vena Cava Filter) 19 
 20 
Introduction 21 
The coronavirus pandemic has altered our personal and professional lives in ways that were 22 
inconceivable only months ago. As the coronavirus (SARs-Co-V2, herein listed as Covid-19) 23 
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spread across the United States, health care workers found themselves on the front lines of the 1 
battle for their patients and, in many cases, their personal well-being and survival.1  2 
On March 13th, the American College of Surgeons issued a recommendation to “review all 3 
scheduled elective procedures with a plan to minimize, postpone, or cancel electively scheduled 4 
operations.”2 On March 14th, Dr. Jerome Brown, the Surgeon General of the United States 5 
reiterated this plea with a tweet “Hospital & healthcare systems, PLEASE CONSIDER 6 
STOPPING ELECTIVE PROCEDURES until we can #FlattenTheCurve!”3 7 
The vascular surgery community quickly responded to these dramatic events.  As a result, the 8 
Society for Vascular Surgery Vascular (SVS) Patient Safety Organization (PSO) Vascular 9 
Quality Initiative (VQI) noted a precipitous decline in registry volumes.  The SVS PSO 10 
conducted two surveys early in the pandemic to assess changes in practice. We first surveyed 11 
VQI data managers to discern pandemic impact on workflow and queried the historical volume 12 
of the M2S registry. Second, we surveyed VQI physicians about practice changes altered in 13 
response to the pandemic. We report the findings and discuss the implications in this practice 14 
management study. 15 
The status quo disrupted 16 
Prior to the Covid-19 pandemic, physicians treating vascular disease regularly performed a 17 
variety of procedures that were elective, urgent, and emergent in nature. Routine elective venous 18 
procedures included varicose vein removal, saphenous vein ablation for reflux, 19 
mechanical/thrombolytic treatment of venous thromboembolism, venous stenting and IVC filter 20 
insertion or removal.  Combined with non-elective arterial disease, urgent and emergent cases for 21 
venous thromboembolism and vascular trauma comprise approximately 30-50% of an active 22 
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vascular surgery practice case mix.4 Many practitioners who focus on venous pathology dedicate 1 
the majority of their case volume to ambulatory venous disease treatment. 2 
The coronavirus pandemic disrupted this status quo threatening the timeliness and efficiency of 3 
care. Physicians were confronted with the dilemma of potential Covid-19 exposure to patients by 4 
bringing them into a hospital or office setting. This influenced physicians to rethink potential 5 
exposure and utilization of hospital resources possibly needed for Covid-19 related admissions.5 6 
Outpatient vascular services and office-based laboratories providing diagnostic and therapeutic 7 
services were also dramatically affected and most apparent for elective venous disease treatment 8 
primarily residing in the outpatient arena. In a global survey by Ng et. al., 86.9% of vascular 9 
surgeons stated that their outpatient services were either suspended or downscaled in response to 10 
the pandemic.6 With little to no preparation, clinical practice for vascular surgeons had to shift 11 
away from preferred face-to-face interactions and adopt a “only if your life (or limb) depends on 12 
it” policy for direct patient contact. Postoperative follow up care and chronic disease 13 
management evolved rapidly through “remote” medicine. Examples of these include 14 
telemedicine through phone calls, video chats, and interactions via the electronic medical record. 15 
This rapid pivot in vascular practice management has only been possible due to advances in 16 
technology and internet access. 17 
A change in practice 18 
During the Society for Vascular Surgery’s webinar conducted on March 27th, Dr. Benjamin 19 
Starnes clearly and passionately stated “the ultimate role of the surgeon in a pandemic is to help 20 
grow hospital capacity by not operating...” to “preserve space, staff and stuff (personal protective 21 
equipment).”7  Vascular surgeons across the nation responded to this “call to inaction” by 22 
developing triage plans for elective, urgent and emergency procedures.8,9   Surgeons and trainees 23 
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were called upon to serve in a variety of new roles to combat the pandemic. The abrupt shutdown 1 
of elective surgery in all forms allowed hospitals and health care systems to draw up capacity 2 
and formulate surge plans in anticipation of an influx of patients with Covid-19.10 3 
Real time data of survey of Data Managers  4 
To determine pandemic impact on VQI workflow, we conducted a survey of VQI centers sent 5 
5/8/2020 and closed 6/15/2020 from over 220 VQI data managers summarized in (Appendix A). 6 
• The majority reported that hospital staff, as opposed to contracted vendors, were 7 
responsible for data collection.  8 
• At the time of the survey in early May, almost 10% of centers restricted procedures to 9 
emergencies only, while over 90% of centers performed urgent and emergent operations.  10 
Forty per cent of centers continued to perform elective procedures with minimal volume 11 
reduction.  Elective cases were scheduled to resume between May 11-24 (53%) and 12 
between May 25-June7 (13%) of centers. One quarter (26%) of centers were unable to 13 
provide a definitive time for restarting elective procedures.  14 
•  75% of abstractors were not furloughed or reassigned.  Thirty percent of respondents 15 
reported having lower case volumes at the time of the survey.  16 
• Variation in the methods for long term follow-up (LTFU) was noted. A third of centers 17 
responded that they were continuing to do face-to-face follow-up with the remainder 18 
adjusting their follow ups to phone contact, phone/video calls or electronic medical 19 
record review.  Twelve percent of the respondents stated that follow-up was currently not 20 
possible.   21 
Survey of VQI member physicians 22 
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To assess the effect on practice, we conducted a 7-question survey of VQI physicians sent 1 
6/2/2020 and closed 7/20/2020 (Appendix B). The response from over 100 physicians is 2 
summarized here: 3 
• A variety of non-mutually exclusive sources were used to guide pandemic change in 4 
operating policy; institutional (61%), societal guidelines (51%) and Center for Disease 5 
Control (CDC)/Center for Medicare Services (CMS) guidelines (30%)  6 
• The majority (74%) reported Operating Policy shift to urgent and emergent cases with 7 
14% restricting to emergency procedures only.  Despite this, one half of respondents 8 
performed ‘Elective’ procedures while restrictive policies were in place due to perceived 9 
need. Urgent cases were interpreted as both symptomatic and ‘time sensitive’ elective 10 
cases as mentioned below 11 
●    Elective procedures considered time sensitive primarily encompassed dialysis access (de 12 
novo 48%, dysfunctional access 72%, asymptomatic (often with larger size criteria) AAA 13 
repair (41%) and PVI for threatened grafts (61%) 14 
●   The majority of centers conducted mandatory COVID-19 testing prior to surgery (79%); 15 
11% reserved testing for symptomatic patients only.  16 
●   A shift to delay repair to a larger size aneurysm was noted in over one quarter of the 17 
respondents. 18 
• The survey did not include questions directed at ambulatory venous practice 19 
In response to the pandemic, the SVS VQI noted precipitous global declines in all registries 20 
including varicose veins (VV) and inferior vena cava filter (IVC) placement as shown in Figure 21 
1.  Operations for VV and IVC registries were compared on a week-by-week basis to 1st quarter 22 
of 2019 in Figure 2. Individually, the VV registry noted a greater decline than did IVC registry 23 
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volumes by a factor of 6.2 to 1.8 reduction, respectively, (Table 1).  Combining VV and IVC 1 
volumes, a nearly 5-fold reduction in average weekly venous procedures were recorded from 2 
weeks 6-9 to weeks 10-13 in 2020 (149 to 77.75, 47.8% decrease) when compared to the same 3 
period in 2019 (160.25 to 145.75, 9.0% decrease).  Geographic differences of the highest 4 
performing regional groups from East and West Coast and Midwest demonstrated nearly 5 
identical curves to registry volume decline as shown in Figure 3. While delay in data entry may 6 
explain part of this decline, such delay would not account for the nearly 5-fold decrease in 7 
average 2020 weekly venous procedural volumes when compared to 1st quarters of both 2018 8 
and 2019. We attribute a significant part of the decline to procedural shutdown across registries 9 
for this period. This is supported by over 75% of data managers being ‘not re-assigned or 10 
furloughed’ and given reduced case volumes, likely had sufficient time for case entry. 11 
Our abbreviated survey did not inquire about ambulatory practice revisions or in office-based 12 
laboratory (OBL’s) performance. Thus, the full impact on venous practice cannot be fully 13 
assessed.  Given the unprecedented shutdown to all non-essential services nationally, it is 14 
reasonable to surmise that ambulatory treatment of venous disorders lessened significantly, as we 15 
continue to hear anecdotally of ongoing treatment of acute thrombophlebitis, infected venous 16 
ulcers and other urgent conditions (JEJ). 17 
The downstream secondary effects of suspending operations are unknown. Approximately 20% 18 
of venous disorders require emergent treatment (thrombolysis, IVC filter insertion/removal, 19 
thrombectomy) requiring hospitalization.  Most can still be performed percutaneously and 20 
contribute to a reduced procedural length of stay. Increased usage of outpatient low molecular 21 
weight heparin injection/oral anticoagulant drug medication in place of inpatient continuous 22 
intravenous heparin infusions can also reduce inpatient bed utilization. 23 
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Covid-19 and peripheral venous complications 1 
Recent research has demonstrated the coronavirus’s ability to produce thrombotic complications 2 
due to the cytokine storm triggering a systemic immune response.11 A  a result, infected patients 3 
are at higher risk of developing a hypercoagulable state with arterial and venous thrombosis. 4 
Excessive inflammation, platelet activation, endothelial dysfunction, and stasis have been 5 
postulated as mechanisms.12 Venous thromboembolic events appear more common than arterial 6 
thromboembolism yet few vascular beds have been spared.13-16 Going forward, vascular surgeons 7 
will need to assess both a patient’s response to a venous procedure but also if prior or current 8 
Covid-19 infection has altered coagulation. Unknown dilemmas such as proper timing to safely 9 
perform a venous ablation in patients who have contracted Covid-19 yet are clinically 10 
asymptomatic are not presently clear.  It is becoming apparent that Covid-19’s hypercoaguable 11 
duration may extend beyond acute hospitalization and into the convalescent stage, thus 12 
anticoagulation may need extended beyond current accepted guidelines. The SVS VQI is 13 
partnering with the Vascular Surgery Covid-19 Collaborative (VASCC) to learn more about the 14 
long-term impact on vascular patients.17 The VQI has incorporated variables in all procedural 15 
registries by late August-early September 2020 on Covid-19 status, infection history and impact 16 
for ongoing monitoring at time of procedure and at long term follow up. 17 
Of concern, are the unknown number of patients who may delay treatment for health issues due 18 
to fear of contracting Covid-19 by seeking medical attention.   Emergency department visits for 19 
acute cardiac events have had a notable decline during the pandemic while a reciprocal rise in ‘at 20 
home’ deaths have been reported.18-19 The health care impact of Covid-19 will need to take into 21 
account indirect collateral morbidity and mortality rates due to patient reluctance or refusal to 22 
seek timely medical attention.20-21 23 
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Invariably, as health care systems look ahead to a return to the business of medicine, guidelines 1 
have been developed for a return to operating.10 Hospitals and surgeons may adapt to elective 2 
procedure backlogs and clinic visits in any number of ways including longer weekday hours or 3 
weekend surgery. 4 
The present analysis is limited by the subjective nature of an elective survey and our attempt to 5 
correlate these results with actual workload volumes in the VQI procedure driven registry.  6 
Attributing a nearly 5-fold difference in venous case volume drop to lack of data entry alone 7 
should be viewed with caution as events surrounding responses to the Covid-19 crises is clearly 8 
multifactorial, noting that 40% of centers continued elective work during this time. Changes in 9 
data manager workflow and long-term follow-up will need to be considered for future quality 10 
reporting and VQI clinical research studies. Survey questions were also directed primarily to the 11 
inpatient setting with an emphasis on arterial procedures and thus did not completely capture 12 
ambulatory venous changes in surgical centers and OBL’s.  Given survey focus, we also cannot 13 
comment on indications or results of venous procedures performed during this time.  That will 14 
require ongoing analysis of center specific data. 15 
 While we analyzed geographic regions by coastal and Midwest locations, we cannot determine 16 
regional distribution to the survey responses at the center level.  VQI centers are in all 50 states.  17 
Each geographic location demonstrated similar rates of decline following mid-March indicating 18 
the national shutdown affected regions equally.  We were unable to determine on a more 19 
granular level the impact on individual centers.   A more detailed reporting of regional 20 
differences in practice variation during pandemic restrictions will require further trend analysis 21 
near the end of 2020, not available at the time of this manuscript.  Given the uncertain future 22 
over the coming one to two years, the US healthcare system will face ongoing challenges. The 23 
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authors expect these challenges to be unevenly distributed over place and time given variations 1 
in state and local guidelines for practice restrictions. Localized outbreaks with clusters of 2 
infection or a resurgence of epidemics may necessitate a similar regional response with a 3 
reduction in elective surgery. 4 
Research into the ramifications of the coronavirus pandemic on all facets of vascular care will 5 
help us provide the best care to our patients.  Venous treatment delays may lead to progression of 6 
thrombotic disease, embolization, or worsen morbidity of post-phlebitic limbs. Vascular 7 
surgeon’s partnership with public health experts and epidemiologists to study the pandemic 8 
impact and our response to the public health crisis should be ongoing. Most importantly, we 9 
must look for new and innovative ways to practice in what will likely be a “new abnormal.”   10 
Conclusions 11 
The vascular surgery community response to the global Covid-19 pandemic during the national 12 
shutdown resulted in a dramatic reduction in elective case volumes with most practitioners 13 
performing emergency and select urgent procedures only.  A 5-fold reduction in venous registry 14 
case volumes was noted when compared to the same period in 2019.  The potential impact of 15 
delaying treatment on vascular disease remains unknown and will require further analysis. The 16 
VQI is moving forward with regional virtual meetings that will provide a forum for study, 17 
reflection, communication, and discussion. 18 
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Q1 Who collects data at your facility? 



















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Contracted vendor 5.43% 12 
Hospital staff 89.14% 197 






Q2 Are you currently performing elective procedures? 


















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Only emergent 9.33% 21 
Urgent + emergent 50.67% 114 
Urgent + emergent + elective 40.00% 90 
 
 




     
 





Q3 When are elective procedures scheduled to start? 
Answered: 204 Skipped: 21 
 
 



















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
May 11th - May 24th 53.43% 109 
May 25th - June 7th 13.24% 27 
June 8th - June 21st 5.88% 12 
June 22nd - July 5th 0.98% 2 






Q4 How many employed VQI abstractors do you have at your center? 


















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
0-1 69.51% 155 
2-3 27.80% 62 
4 or more 2.69% 6 
 
 
          
 
       
 





Q5 How many of your employed VQI abstractors been re-deployed? 























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
0 75.34% 168 
1 19.73% 44 
2-3 4.48% 10 
4 or more 0.45% 1 
 
 
   







Q6 How many of your employed VQI abstractors been furloughed? 























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
0 75.00% 168 
1 19.64% 44 
2-3 4.91% 11 
4 or more 0.45% 1 
 
 
   







Q7 Are you still abstracting current procedures? 























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Yes, no change 37.33% 84 
Yes, but limited by staffing 23.11% 52 
Yes, but limited due to low case volume 29.78% 67 




       
  
   
 




Q8 What is your current process to collect LTFU between 9-21 months? 
Answered: 220 Skipped: 5 





0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
ANSWER CHOICES RESPONSES 
Face to face 34.55% 76 
Phone 30.45% 67 
No follow-up possible 10.91% 24 
Other source 24.09% 53 
# LIST OTHER SOURCE(S) DATE 
1 clinic 6/5/2020 12:24 PM 
2 Per office records. Virtual visits. 6/5/2020 12:15 PM 
3 Lot's of the office visits were canceled and some patient does not want to come back, the follow 
up rate is lower... 
6/5/2020 11:05 AM 
4 e records 6/5/2020 11:01 AM 
5 Medical records 6/5/2020 10:59 AM 
6 televisit 6/5/2020 10:59 AM 
7 currently majority telehealth 5/26/2020 10:26 AM 
8 phone but it wouldnt let me choose more than one / and internet if i think pt. is deceased 5/20/2020 9:04 AM 
9 any combination of these sources are used to capture follow up data, email, phone calls, 
medical records search 
5/18/2020 2:02 PM 
10 collect from EMR 5/18/2020 10:04 AM 
11 Epic 5/15/2020 9:49 AM 
12 EMR review 5/14/2020 11:44 AM 
13 EPIC 5/13/2020 12:21 PM 
14 Currently pursue followup in MD office records but not active due to office reduction in force 
and office visits 
5/13/2020 10:39 AM 
15 Medical record 5/13/2020 8:11 AM 
16 TELEMEDICINE OR FACE TO FACE 5/12/2020 8:45 AM 
17 chart and care everywhere. We also call pts and PCP's 5/11/2020 4:38 PM 
18 Clinic medical record 5/11/2020 3:54 PM 
19 EMR 5/11/2020 2:09 PM 
20 Medical records review 5/11/2020 12:46 PM 
21 LTFU completed by physician office 5/11/2020 6:07 AM 
22 havent though about it 5/10/2020 2:53 PM 
23 Office visit records in EPIC 5/9/2020 4:17 PM 
24 Unknown - currently clinic as far as I know 5/9/2020 9:06 AM 
25 telehealth 5/9/2020 6:09 AM 
26 Clinic is closed but will reopen soon 5/8/2020 4:00 PM 
27 video visits 5/8/2020 3:35 PM 
28 Telehealth 5/8/2020 3:24 PM 
29 Telehealth with videoconferencing 5/8/2020 2:52 PM 
30 EMR and phone calls 5/8/2020 1:40 PM 
31 use all available sources 5/8/2020 1:39 PM 
32 we try to use all tools available to us however very problematic at times (clinic visits, EMR, 
some will have no F/U) 
5/8/2020 1:32 PM 
33 We just started seeing patients in office again. Previously had been phone encounters. 5/8/2020 1:10 PM 
34 unknown 5/8/2020 1:04 PM 
35 unknown 5/8/2020 1:04 PM 
 
 
36 Medical Records of face to face appointments or telehealth appts. 5/8/2020 1:03 PM 
37 electronic records 5/8/2020 12:59 PM 
38 We pull the data from the shared EMR. As long as patient's have given authorization, we can 
access at least parts of the EMR from health systems across our region. 
5/8/2020 12:43 PM 
39 Medical Record 5/8/2020 12:30 PM 
40 situational 5/8/2020 12:30 PM 
41 As we are new to VQI it is not time for follow-up 5/8/2020 12:27 PM 
42 combination of phone, face to face, other source. Imaging is just more difficult 5/8/2020 12:24 PM 
43 most have been rescheduled-some will fall out of 21 months 5/8/2020 12:18 PM 
44 Tele med and others have been rescheduled and with rescheduling are likely to fall out of 9-21 
months. 
5/8/2020 12:18 PM 
45 Electronic Health Records 5/8/2020 12:16 PM 
46 EHR review. 5/8/2020 12:16 PM 
47 limited as only one abstractor who has been furloughed 5/8/2020 12:16 PM 
48 Telehealth and finding notes that qualify in the medical record 5/8/2020 12:15 PM 
49 abstract through chart review after visit 5/8/2020 12:14 PM 
50 other physician contact within 9-21 months 5/8/2020 12:12 PM 
51 We will accept documentation of telehealth visits with surgeon's office or documentation in the 
medical record if they have been hospitalized within the 9-21 months 
5/8/2020 12:10 PM 
52 electronic medical record review 5/8/2020 12:10 PM 
53 Medical record documentation 5/8/2020 12:09 PM 






















Yes, very few 




No, none for 
now 
Q9 Are you still abstracting LTFU? 






















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Yes, no change 35.78% 78 
Yes, but mostly by phone 17.89% 39 
Yes, very few - limited by staffing 22.94% 50 














Q1 Describe Operating Policy change (if any) as a response to the 
COVID-19 pandemic: 























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
No change 0.00% 0 
Emergency cases only 14.29% 15 
Urgent and Emergency cases 74.29% 78 
Other (please specify) 11.43% 12 
 
 
   
       
  
 
# OTHER (PLEASE SPECIFY) DATE 
1 Emergent, urgent and time sensitive elective 7/10/2020 7:21 AM 
2 Our main institution did not change much, our small hospitals became emergency only 7/7/2020 1:42 PM 
3 urgent, emergent, and what we deemed "essential" cases 7/7/2020 10:37 AM 
4 "essential" cases including urgent and emergent but also AAA>6cm, TAAA>7cm, CLTI with 
tissue loss, symptomatic CEA/CAS 
6/10/2020 5:56 AM 
5 Was emergency only but back to normal as of May. 6/5/2020 9:03 AM 
6 Initially emergency only, then urgent, next week we start semi-elective 6/4/2020 4:49 PM 
7 Closed office for 6 weeks until elective cases permitted by state 6/4/2020 3:11 PM 
8 selective elective cases being perrformed 6/4/2020 12:21 PM 
9 priority, urgent, and emergent cases 6/4/2020 11:01 AM 
10 Urgent, emergent and "time-sensitive" elective where a delay would be harmful 6/3/2020 7:52 PM 
11 Initially Urgent and Emergency, now back to all 6/3/2020 9:28 AM 




Q2 If Operating Policy changed, what resource guide was used? 





















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
No change 0.00% 0 
Institution or Department mandate 60.95% 64 
Society resource guide such as ACS, ACC, SCAI 51.43% 54 
CDC/CMS Federal guide 30.48% 32 




# OTHER (PLEASE SPECIFY) DATE 
1 state recomendations 7/8/2020 3:35 PM 
2 NY state government mandates 7/7/2020 1:42 PM 
3 order of state of Ohio 7/7/2020 10:37 AM 
4 state of Ohio medical director 6/10/2020 5:56 AM 
5 Provincial Ministry of Health 6/9/2020 9:14 PM 
6 state 6/5/2020 10:55 AM 
7 Hospital and governor mandata 6/4/2020 4:49 PM 
8 Ontario Priority ranking 6/4/2020 3:08 PM 
9 SVS guidelines and personal decision by practice 6/4/2020 1:52 PM 




Q3 Were any elective procedures continued during this time? 















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Yes 49.52% 52 
No 50.48% 53 
          
 
     
 





Q4 If yes, please indicate which ones: 

























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
De novo dialysis access procedures 47.69% 31 
AV access dysfunction (thrombosis, steal, revision, etc.) 72.31% 47 
Asymptomatic carotid artery disease 9.23% 6 
Asymptomatic AAA 41.54% 27 
Claudicants 3.08% 2 
PVI patients with graft threatening stenosis 61.54% 40 
Other (please specify) 18.46% 12 
 
 
# OTHER (PLEASE SPECIFY) DATE 
1 R IV and V CLTI 7/11/2020 8:22 AM 
2 cases considered on an individual basis 7/8/2020 3:35 PM 
3 Large AAAs, symptomatic carotids, gangrene 7/7/2020 10:11 PM 
4 Large AAA 7/7/2020 1:55 PM 
5 In our main institution, we did any type of vascular case if patient wanted it during COVID, in 
our small hospitals we hardly operated but continued angios 
7/7/2020 1:42 PM 
6 office based procedures 6/12/2020 9:48 AM 
7 see above descriptions of what we categorized as large asymptomatic aneurysms and CLTI 6/10/2020 5:56 AM 
8 severe critical limb ischemia with expected imminent limb loss without revascularization, 
symptomatic carotid stenosis with >70% stenosis 
6/6/2020 1:34 PM 
9 CLI pts for bypass, Symptomatic carotids, AAA or TAAAs by EVAR if >6 or 6.5 respectively 6/4/2020 3:08 PM 
10 "elective" is the worng terminology to use 6/4/2020 12:29 PM 
11 Very large AAA, rest pain/tissue loss PAD cases 6/3/2020 7:52 PM 




Q5 Is COVID-19 testing mandatory before OR/Cath lab/Angio suite 
procedure? 


















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
Yes, all patients 79.05% 83 
Yes, symptomatic patients only 11.43% 12 
No 9.52% 10 
   








Q6 If a decision to treat AAA (Open AAA or EVAR) changed from SVS 
guidelines, what size criteria was used? 


















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
No change-followed SVS Guidelines 52.04% 51 
Male > 6.0 cm 26.53% 26 
Male > 7.0 cm 21.43% 21 
 
 
     
    





Q7 If a decision to treat AAA (Open AAA or EVAR) changed from SVS 
guidelines, what size criteria was used? 


















0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
ANSWER CHOICES RESPONSES 
No change-followed SVS Guidelines 51.04% 49 
Female > 5.5 cm 26.04% 25 
Female > 6.5 cm 22.92% 22 
 
 
     
    
   
 
Average Weekly Registry Procedure Volumes 2018-2020 
 
VV = Varicose Vein    IVC = IVC Filter 
 
Procedure Volume Weeks 6-9 Weeks 10-13 Comparison Change 
(%) 
2018         VV 
 










2019         VV 
 










2020         VV 
             














Table demonstrating Average weekly volumes for Weeks 6-9 and Weeks 10-13 in first Quarter 
of 2018-2020.   A 6.2-fold decrease in VV volume and a 1.8-fold decrease in IVC filter volume 
from 2019 to 2020 is demonstrated.  This represents a 5-fold reduction for all 2020 venous 
procedures compared to 2019. 
Figure 1: 
Graph showing VQI registry data of weekly vascular surgical procedure volumes during the 
COVID-19 pandemic. Week 1 = Jan 4; Week 5 = Feb 1.  Line at week 11 showing steep drop-off 
in case volume after 3/15/2020. VV = Varicose Vein; IVCF = Inferior Vena Cava Filter 
VQI 2020 Procedure Volume By Week 
Data entered as of 6/30/2020 
VV 
IVCF 


































Graph comparing 4-week average procedural volume in 2019 for VV and IVC registries to VQI 
data during the COVID-19 pandemic in 2020.  The number over the red and blue lines represents 
percent change in a four-week volume during weeks 5-8 and weeks 10-13. 
 For reference:  Week 1 = Jan 4; Week 5 = Feb 1; March 15 = Week 11 when national shutdown 
occurred. 
VQI Venous Procedure Volume By Week 





2020 data entered as of 6/30/2020 
2020 weekly average over interval 
2019 data entered as of 6/30/2019 
2019 weekly average over interval 

































Graph demonstrating a sample of regional distribution from high procedural volume centers of 
varicose vein and vena cava filter insertion.  1st quarter weeks 1-13 listed for 2019 and 2020.  
March 15 = Week 11 when national shutdown occurred. 
 
VQI Venous Procedure Volume By Week 
Eastern Region (2020 vs 2019) 
VQI Venous Procedure Volume By Week 
Midwest Region (2020 vs 2019) 
VQI Venous Procedure Volume By Week 
Western Region (2020 vs 2019) 
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Week Week 
2020 data entered as of 6/30/2020 
2020 weekly average over interval 
  2019 data entered as of 6/30/2019 




































































Table 1: Table demonstrating Average weekly volumes for Weeks 6-9 and Weeks 10-13 in first 2 
Quarter of 2018-2020.   A 6.2-fold decrease in VV volume and a 1.8-fold decrease in IVC filter 3 
volume from 2019 to 2020 is demonstrated.  This represents a 5-fold reduction for all 2020 4 
venous procedures compared to 2019. 5 
6 
Figure 1: Graph showing VQI registry data of weekly vascular surgical procedure volumes 7 
during the COVID-19 pandemic. Week 1 = Jan 4; Week 5 = Feb 1.  Line at week 11 showing 8 
steep drop-off in case volume after 3/15/2020. VV = Varicose Vein; IVCF = Inferior Vena Cava 9 
Filter 10 
11 
Figure 2: Graph comparing 4-week average procedural volume in 2019 for VV and IVC 12 
registries to VQI data during the COVID-19 pandemic in 2020.  The number over the red and 13 
blue lines represents percent change in a four-week volume during weeks 5-8 and weeks 10-13. 14 
 For reference:  Week 1 = Jan 4; Week 5 = Feb 1; March 15 = Week 11 when national shutdown 15 
occurred. 16 
17 
Figure 3: Graph demonstrating a sample of regional distribution from high procedural volume 18 
centers of varicose vein and vena cava filter insertion.  1st quarter weeks 1-13 listed for 2019 and 19 
2020.  March 15 = Week 11 when national shutdown occurred. 20 
21 
